NGN CAPITAL
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector. The fund focuses specifically on investments in the healthcare, pharmaceutical, and biotech sectors including drug products, medical devices, diagnostics, and healthcare services.
NGN CAPITAL
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
2003-07-01
Status:
Active
Contact:
+1 212 972 0077
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta Google Font API LetsEncrypt Content Delivery Network Organization Schema Typekit LocalBusiness Schema Squarespace
Similar Organizations
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
SnowMark Corporation
SnowMark Corporation is a venture capital firm specializing in investments in technology, healthcare informatics, and real estate sectors.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-07-24 | Exosome Diagnostics | NGN Capital investment in Series C - Exosome Diagnostics | 30 M USD |
| 2016-01-07 | Exosome Diagnostics | NGN Capital investment in Series B - Exosome Diagnostics | 16 M USD |
| 2015-09-02 | Exosome Diagnostics | NGN Capital investment in Series B - Exosome Diagnostics | 17.6 M USD |
| 2014-03-11 | Exosome Diagnostics | NGN Capital investment in Series B - Exosome Diagnostics | 27 M USD |
| 2014-01-01 | PIN Pharma | NGN Capital investment in Series A - PIN Pharma | 6.75 M USD |
| 2013-11-27 | Endosense | NGN Capital investment in Series C - Endosense | 37.4 M CHF |
| 2012-11-27 | Endosense | NGN Capital investment in Series C - Endosense | 40.3 M USD |
| 2012-07-23 | Cerapedics | NGN Capital investment in Series C - Cerapedics | 19 M USD |
| 2010-12-17 | Small Bone Innovations | NGN Capital investment in Series F - Small Bone Innovations | 15 M USD |
| 2010-07-20 | Artisan Pharma | NGN Capital investment in Series C - Artisan Pharma | 3 M USD |
More informations about "NGN Capital"
NGN Capital LLC
LOCATION. 60 Long Ridge Road. Suite 402. Stamford, CT 06902 . PHONE (212) 972-0077. FAX (212) 972-0080See details»
NGN Capital - Crunchbase Investor Profile & Investments
Nov 28, 2012 · NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector. The fund focuses specifically on investments in the healthcare, pharmaceutical, and biotech sectors including …See details»
Team — NGN Capital LLC
John R. Costantino is a Senior Advisor to and formerly Managing General Partner of NGN Capital LLC, a series of healthcare focused venture funds totaling approximately $450 million, with offices in New York and Heidelberg, Germany.See details»
About NGN Capital
NGN Capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage …See details»
NGN Capital - Investments, Portfolio & Company Exits - Crunchbase
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.See details»
NGN Capital investment portfolio | PitchBook
Founded in 2003, NGN Capital is a venture capital firm based in Stamford, Connecticut. The firm prefers to invest in companies operating in the healthcare sectors across the United States …See details»
NGN Capital LLC - Company Profile and News - Bloomberg Markets
NGN Capital LLC operates as a venture capital firm. The Company invests in healthcare and biotechnology segments including drug products, medical devices, and other healthcare …See details»
NGN Capital - LinkedIn
NGN Capital | 238 followers on LinkedIn. ... Kenneth J. Gorelick MD, FACP, FCCP Managing Director at Zymo Consulting Group LLCSee details»
NGN Capital | Institution Profile - Private Equity International
Founded in 2003, NGN Capital is a Connecticut-headquartered private equity firm with offices in Germany and New York. The firm targets early-stage investments in biotech and healthcare …See details»
NGN Capital - Funding, Financials, Valuation & Investors
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.See details»
NGN Capital Profile: Summary - OpenSecrets
NGN Capital organization profile. Contributions in the 2024 cycle: $5,500. Lobbying in 2024: $0. Outside Spending in the 2024 cycle: $0.See details»
Kenneth Abramowitz | Kenneth Abramowitz
As managing general partner and co-founder of NGN Capital, Abramowitz oversees a half-billion worldwide healthcare venture capital fund. He joined NGN from the Carlyle Group in New York …See details»
NGN Capital - Contacts, Employees, Board Members, Advisors
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.See details»
Portfolio Companies — NGN Capital LLC
LOCATION. 60 Long Ridge Road. Suite 402. Stamford, CT 06902 . PHONE (212) 972-0077. FAX (212) 972-0080See details»
Home — NGN Capital LLC
NGN Capital LLC News Peter Johann Full Bio John Costantino Full Bio Kenneth Abramowitz Full Bio About NGN Capital Team Portfolio Companies Peter Johann Full Bio John ...See details»
KEMRI, UK firm sign Sh15bn deal to boost Kenya’s ... - Capital News
18 hours ago · NAIROBI, Kenya, Nov 28- The Kenya Medical Research Institute (KEMRI) has signed a Sh15 billion MoU with Wellcome Trust, a UK charitable organization, and the …See details»
Kenneth S. Abramowitz - Co-Founder & General Partner @ NGN …
Kenneth S. Abramowitz is a co-founder and Managing General Partner of NGN Capital. He joined NGN Capital from The Carlyle Group in New York where he was Managing Director from 2001 …See details»
John Costantino Full Bio — NGN Capital LLC
John R. Costantino is a Senior Advisor to and formerly Managing General Partner of NGN Capital LLC, a series of healthcare focused venture funds totaling approximately $450 million, with …See details»
John R. Costantino - Owner @ NGN Capital - Crunchbase
John R. Costantino is the Board of Directors at ACT Biotech. John R. Costantino studied at Fordham University and Fordham University. There is no recent news or activity for this profile. …See details»
Peter Johann Full Bio — NGN Capital LLC
Dr. Peter Johann is a Managing General Partner of NGN Capital. He joined from Boehringer Ingelheim where he was the Division Head of Corporate Development. Dr. Johann has …See details»